Icotrokinra
Chemical compound
Icotrokinra, sold under the brand name Icotyde, is a medication used for the treatment of plaque psoriasis. It is a cyclic peptide that functions as a selective interleukin 23 (IL-23) receptor antagonist.
Nº Q131418207 ★
Común · Saberes
Icotrokinra
Chemical compound
Icotrokinra, sold under the brand name Icotyde, is a medication used for the treatment of plaque psoriasis. It is a cyclic peptide that functions as a selective interleukin 23 (IL-23) receptor antagonist.
Último precio
—
Precio mínimo
—
Mediana 7 d
—
Ventas 30 d
0
Rango 30 d
—
En circulación
0
Cotización
mediana
mín – máx
ventas
Sin ventas en el periodo
Ver tabla
| Fecha | mediana | Mín | Máx | ventas |
|---|
Historial de ventas
- Última venta
- —
- Media 30 d
- —
- Mínimo 30 d
- —
- Máximo 30 d
- —
- Ventas 7 d
- 0
- Ventas 30 d
- 0
Aún no hay ventas.
Ventas anónimas: sin comprador ni vendedor. Las cifras solo cuentan ventas entre jugadores.
En Wikipedia
Texto en inglés Aún no hay artículo en tu idioma: extracto en inglés.
Icotrokinra, sold under the brand name Icotyde, is a medication used for the treatment of plaque psoriasis. It is a cyclic peptide that functions as a selective interleukin 23 (IL-23) receptor antagonist. It is a synthetic peptide that binds selectively to the IL-23 receptor (IL-23R) with high affinity and competitively antagonizes the binding of IL-23. It is an immunosuppressant and interleukin inhibitor. It is being developed by Johnson & Johnson. Icotrokinra was approved for medical use in the United States in March 2026.
Texto: Wikipedia en inglés, CC BY-SA 4.0. · Imagen: User:Innerstream (Public domain) ·
